Relationship between Serum 25-Hydroxyvitamin D and Lower Extremity Arterial Disease in Type 2 Diabetes Mellitus Patients and the Analysis of the Intervention of Vitamin D

Table 3

The comparison of characteristics before and after treatment in Groups DM3 and DM4.

Variable	Group DM4 ()			Group DM3 ()
	0 w	12 w	-value	0 w	12 w	-value
TC (mmol/L)	5.12 ± 0.43	5.25 ± 0.32	−0.13 ± 0.47	5.17 ± 0.41	5.3 ± 0.38	−0.13 ± 0.5
TG (mmol/L)	2.47 ± 0.35	2.33 ± 0.19^b	−0.14 ± 0.38	2.47 ± 0.40	2.50 ± 0.32	−0.03 ± 0.52
LDL (mmol/L)	3.18 ± 0.72	2.43 ± 0.41^a,b	−0.72 ± 0.85	2.91 ± 0.73	3.03 ± 0.60	−0.12 ± 1.00
HDL (mmol/L)	1.12 ± 0.11	1.09 ± 0.26	−0.03 ± 0.27	1.11 ± 0.12	1.19 ± 0.21	−0.08 ± 0.25
25(OH)D (ng/mL)	12.39 ± 8.37	19.27 ± 2.33^a,b	−6.89 ± 9.03^b	13.30 ± 7.76	11.66 ± 2.37	1.63 ± 7.63
RBP4 (μg/mL)	39.09 ± 2.32	25.33 ± 1.68^a,b	13.76 ± 3.20^b	39.02 ± 1.97	35.44 ± 2.17^a	3.58 ± 3.05
BMI (kg/m^2)	25.05 ± 3.30	23.95 ± 2.81	1.10 ± 4.11	24.09 ± 3.77	23.71 ± 2.85	0.38 ± 4.65
HbA1c (%)	7.38 ± 0.65	5.95 ± 0.48^a,b	1.43 ± 0.87^b	7.35 ± 0.78	6.74 ± 0.59^a	0.61 ± 0.92
WHR	0.87 ± 0.04	0.87 ± 0.04	0.00 ± 0.05	0.87 ± 0.04	0.86 ± 0.03	0.01 ± 0.05

Note: comparison within the group, ^a; comparison between two groups, ^b.